Buy CJC-1295 — USA-Made, COA per Lot
PX1 Research provides USA-synthesized, high-purity CJC-1295 for advanced preclinical research and laboratory assays. Every lot undergoes rigorous HPLC and mass spectrometry verification alongside stringent endotoxin testing to ensure precise experimental reproducibility.
Quick answer
PX1 Research provides USA-synthesized, high-purity CJC-1295 for advanced preclinical research and laboratory assays. Every lot undergoes rigorous HPLC and mass spectrometry verification alongside stringent endotoxin testing to ensure precise experimental reproducibility.
Key takeaways
- When purchasing compounds for in vitro or animal models, investigators require complete assurance regarding chemical purity, sequence integrity, and stability.
- [CJC-1295](/research-peptides/cjc-1295-no-dac) was engineered as a modified form of GHRH (1-29), incorporating amino acid substitutions at positions 2, 8, 15, and 27.
- Procuring research compounds from overseas vendors frequently exposes laboratories to unverified purity levels, variable trifluoroacetic acid (TFA) salt residues, and elevated endotoxin content.
- Academic and private laboratories utilize [CJC-1295](/research-peptides/cjc-1295-no-dac) across various preclinical study designs.
Sourcing High-Purity CJC-1295 for Laboratory Research
When purchasing compounds for in vitro or animal models, investigators require complete assurance regarding chemical purity, sequence integrity, and stability. CJC-1295 is a synthetic 29-amino acid tetrasubstituted peptide analog of growth hormone-releasing hormone (GHRH). In preclinical literature, researchers utilize CJC-1295 to evaluate sustained somatotrophic stimulation, baseline pituitary secretion dynamics, and downstream cellular repair pathways.
Choosing a domestic supplier for research peptides eliminates common supply chain vulnerabilities, such as temperature degradation during extended international transport and batch-to-batch variability. PX1 Research manufactures CJC-1295 within GMP-compliant facilities in the United States, providing verifiable analytical documentation with every lot. Investigators who buy CJC-1295 from PX1 receive fully validated reagents ready for quantitative bioassays.
CJC-1295 Chemical Structure and Pharmacological Profile
CJC-1295 was engineered as a modified form of GHRH (1-29), incorporating amino acid substitutions at positions 2, 8, 15, and 27. These modification points—specifically D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27—confer significant resistance to enzymatic degradation by dipeptidyl peptidase IV (DPP-IV).
In preclinical models, this structural optimization extends the biological half-life significantly compared to native GHRH (1-29). As a GHRH analog, CJC-1295 selectively binds to and activates the growth hormone-releasing hormone receptor (GHRH-R) on anterior pituitary somatotrophs. This binding cascade triggers intracellular cAMP accumulation, promoting the pulsatile release of endogenous growth hormone (GH) and subsequently elevating systemic insulin-like growth factor 1 (IGF-1) levels in animal subjects.
PX1 Research vs. Overseas Peptide Suppliers
Procuring research compounds from overseas vendors frequently exposes laboratories to unverified purity levels, variable trifluoroacetic acid (TFA) salt residues, and elevated endotoxin content. Unregulated offshore production often lacks batch-specific quality verification, presenting significant risks of experimental confounding or cell culture toxicity.
PX1 Research addresses these challenges by subjecting all CJC-1295 lots to rigorous domestic quality assurance protocols. Every batch synthesized in our USA facilities is tested by an independent ISO 17025 accredited laboratory. Our analytical verification includes High-Performance Liquid Chromatography (HPLC) for chemical purity analysis, Mass Spectrometry (MS) for exact molecular weight confirmation, and Chromogenic LAL assays for quantitative endotoxin measurement. This level of quality control ensures that laboratories receive consistently pure reagents without custom delays or regulatory clearance issues.
Preclinical Applications in Tissue Repair and Metabolic Research
Academic and private laboratories utilize CJC-1295 across various preclinical study designs. Because CJC-1295 acts as a sustained GHRH analog, it serves as a primary candidate for investigating the downstream effects of continuous versus pulsatile growth hormone elevation. In animal models of skeletal muscle trauma, tendon injury, and cutaneous wound healing, researchers examine how elevated IGF-1 concentrations alter extracellular matrix remodeling, collagen deposition, and localized cellular proliferation.
Additionally, rodent studies evaluate the role of sustained somatotrophic axis activation in lipid metabolism, nitrogen retention, and bone mineral density. In vitro assays using primary pituitary cell cultures explore receptor internalization kinetics and desensitization patterns following prolonged exposure to synthetic GHRH agonists. Researchers tracking cellular signal transduction pathways can review analytical references in the PX1 Research Hub.
Comparative Analysis: CJC-1295 vs. Other Secretagogues and GHRH Analogs
Selecting the appropriate secretagogue depends on the target receptor family and desired kinetic profile in the experimental design. While CJC-1295 functions directly as a GHRH-R agonist, researchers frequently compare its activity against alternative GHRH analogs such as tesamorelin and sermorelin. Sermorelin represents the native 1-29 sequence without non-natural amino acid substitutions, exhibiting a rapid clearance rate suitable for acute secretion assays. Tesamorelin features a hexenoyl moiety attached to the N-terminal residue, conferring modified lipolytic selectivity in metabolic rodent models.
In contrast to pure GHRH analogs, ghrelin receptor agonists like ipamorelin target the growth hormone secretagogue receptor (GHS-R1a). Dual-stimulation protocols in preclinical literature often combine a GHRH analog with selective growth hormone secretagogues to evaluate synergistic growth hormone release dynamics without inducing excess cortisol or prolactin secretion. For studies investigating localized tissue regeneration alongside systemic axis stimulation, investigators may also evaluate pleiotropic tissue repair compounds such as BPC-157.
Analytical Rigor: HPLC, Mass Spectrometry, and Endotoxin Testing
Experimental validity depends entirely on compound integrity. PX1 Research enforces a baseline purity threshold of at least 98.0% for all synthesized CJC-1295 lots. High-Performance Liquid Chromatography (HPLC) is conducted using reverse-phase columns to isolate and quantify any related peptide impurities or synthesis side-products.
Mass Spectrometry (MS) analysis provides exact mass determination, verifying that the molecular structure precisely matches the theoretical mass of CJC-1295. Furthermore, because bacterial endotoxins (lipopolysaccharides) induce non-specific inflammatory responses in cell cultures and animal models, PX1 conducts quantitative endotoxin testing on every lot, ensuring levels remain well below standard laboratory threshold limits (typically < 0.1 EU/mg).
Laboratory Handling, Reconstitution, and Storage Standards
CJC-1295 is supplied as a sterile, lyophilized (freeze-dried) cake or powder packaged in glass vials under inert gas. To preserve peptide stability prior to reconstituting, un-reconstituted vials should be stored in a freezer at -20°C or -80°C, protected from light exposure.
For laboratory reconstitution, researchers should use sterile Bacteriostatic Water or sterile 0.9% Sodium Chloride Injection, depending on the requirements of the downstream assay. Reconstitution should be performed by gently introducing the solvent along the glass inner wall of the vial, followed by gentle swirling. Direct agitation, shaking, or vortexing must be avoided to prevent shear-induced peptide aggregation. Post-reconstitution, liquid aliquots should be refrigerated at 2°C to 8°C and used within defined experimental timeframes to prevent enzymatic or hydrolytic degradation.
Domestic Logistics and Supply Chain Reliability
Research timelines require dependable, fast fulfillment without customs holds or unpredictable international transit times. PX1 Research operates dual fulfillment hubs located in California and Arizona, enabling rapid distribution across North America.
Orders placed before standard daily cutoffs qualify for same-day dispatch Monday through Friday. All shipments utilize protective insulated packaging designed to cushion delicate lyophilized vials against mechanical shock during transport. Laboratories requiring bulk quantities or dedicated recurring deliveries for longitudinal animal protocols can coordinate customized logistics through our bulk research procurement team.
Frequently Asked Questions
What is the certified purity level of PX1 Research CJC-1295?
PX1 Research guarantees a chemical purity of ≥98.0% for every CJC-1295 lot. Batch-specific Certificates of Analysis (COAs), generated via reverse-phase HPLC and mass spectrometry, are available for download with every purchase.
How does CJC-1295 differ from Sermorelin in preclinical study designs?
CJC-1295 contains four amino acid substitutions that protect the peptide against cleavage by DPP-IV enzymes, resulting in a substantially longer elimination half-life compared to Sermorelin, which retains the unmodified native GHRH (1-29) sequence.
Are PX1 Research CJC-1295 batches tested for bacterial endotoxins?
Yes. Every lot undergoes quantitative Chromogenic LAL testing to ensure endotoxin levels remain below stringent laboratory thresholds (< 0.1 EU/mg), preventing non-specific inflammatory artifacts in cell or animal models.
What solvent is recommended for reconstituting CJC-1295 for laboratory use?
Lyophilized CJC-1295 is typically reconstituted using laboratory-grade Bacteriostatic Water (0.9% benzyl alcohol) or sterile 0.9% Sodium Chloride, depending on the sensitivity of the planned in vitro or in vivo bioassay.
Where is PX1 Research CJC-1295 synthesized and shipped from?
All CJC-1295 is synthesized in state-of-the-art USA facilities and dispatched directly from our domestic fulfillment centers located in California and Arizona.
What is the optimal storage condition for lyophilized CJC-1295 vials?
Dry, lyophilized CJC-1295 vials should be stored at -20°C to -80°C away from light exposure. Under these conditions, the compound maintains chemical stability for extended storage periods.
Can PX1 Research provide bulk quantities for high-throughput laboratory screening?
Yes. Institutional accounts, academic laboratories, and contract research organizations (CROs) can request custom vial sizes, bulk powder lots, or scheduled shipment recurring orders via our wholesale portal.
Is CJC-1295 approved for human therapeutic use or clinical administration?
No. CJC-1295 supplied by PX1 Research is strictly a research chemical designated for laboratory, in vitro, and preclinical animal research only. It is not for human or veterinary diagnostic, therapeutic, or clinical application.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.